Biktarvy, formally known as bictegravir, is a powerful single-tablet therapy for treating HIV infection. This drug combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the HIV's ability to replicate within the body, considerably reducing the viral load. For many individuals, Biktar